Literature DB >> 17659875

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

Jeffrey M Rogers1, Peter K Panegyres.   

Abstract

Cognitive impairment is common in multiple sclerosis (MS), occurring at all stages of the disease, and can be a major source of vocational disability, social impairment, and impoverished quality of life. Dysfunction in free recall from long-term memory, speed of information processing, working memory, and abstract reasoning are frequently observed in MS. Despite weak correlation with disease duration and physical disability status, the degree of cognitive impairment in MS has been related to the extent of topographically specific neuronal tissue damage and loss. Additional clinical factors including disease course, fatigue, affective disturbance, and medication can impact on the degree of MS-related cognitive impairment. We suggest that the symbol digits modalities test, paced auditory serial addition task, the clock drawing test and the MS neuropsychological screening questionnaire be considered as valid and relevant screening tests for cognitive impairment in MS.

Entities:  

Mesh:

Year:  2007        PMID: 17659875     DOI: 10.1016/j.jocn.2007.02.006

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  43 in total

1.  Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing-remitting multiple sclerosis patients.

Authors:  Michael Amann; Lea Sybil Dössegger; Iris-Katharina Penner; Jochen Gunther Hirsch; Carla Raselli; Pasquale Calabrese; Katrin Weier; Ernst-Wilhelm Radü; Ludwig Kappos; Achim Gass
Journal:  Hum Brain Mapp       Date:  2010-11-12       Impact factor: 5.038

2.  Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Authors:  Francesco Patti; Maria Pia Amato; Stefano Bastianello; Luisa Caniatti; Elisabetta Di Monte; Fausto Lijoi; Benedetta Goretti; Silvia Messina; Orietta Picconi; Maria Rosalia Tola; Maria Trojano
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.

Authors:  Suzanne L Barker-Collo; Suzanne C Purdy
Journal:  Int J MS Care       Date:  2013

4.  The Need for Screening, Assessment, and Treatment for Cognitive Dysfunction in Multiple Sclerosis: Results of a Multidisciplinary CMSC Consensus Conference, September 24, 2010.

Authors:  Frederick W Foley; Ralph H B Benedict; Elizabeth S Gromisch; John Deluca
Journal:  Int J MS Care       Date:  2012

5.  Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?

Authors:  Jessica Burggraaff; Dirk L Knol; Bernard M J Uitdehaag
Journal:  Eur Neurol       Date:  2017-03-21       Impact factor: 1.710

6.  Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery.

Authors:  Bilge Piri Cinar; Görkem Kösehasanoğulları; Pinar Yigit; Serkan Ozakbas
Journal:  Neurol Sci       Date:  2016-11-24       Impact factor: 3.307

7.  Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Authors:  Stefania Barone; Maria Eugenia Caligiuri; Paola Valentino; Andrea Cherubini; Carmelina Chiriaco; Alfredo Granata; Enrica Filippelli; Tiziana Tallarico; Rita Nisticò; Aldo Quattrone
Journal:  J Neurol       Date:  2018-07-26       Impact factor: 4.849

Review 8.  Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.

Authors:  Hao Meng; Jun Xu; Chenling Pan; Jiaxing Cheng; Yue Hu; Yin Hong; Yuehai Shen; Hua Dai
Journal:  J Neurol       Date:  2016-12-01       Impact factor: 4.849

9.  The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.

Authors:  D Obradovic; M Petrovic; I Antanasijevic; J Marinkovic; T Stojanovic; S Obradovic
Journal:  Neurol Sci       Date:  2012-05-03       Impact factor: 3.307

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.